217 related articles for article (PubMed ID: 23204230)
21. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
[TBL] [Abstract][Full Text] [Related]
22. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
[TBL] [Abstract][Full Text] [Related]
23. Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.
Bedke T; Pretsch L; Karakhanova S; Enk AH; Mahnke K
J Immunol; 2010 May; 184(10):5562-70. PubMed ID: 20382886
[TBL] [Abstract][Full Text] [Related]
24. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
25. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
26. Myosin IIa activation is crucial in breast cancer derived galectin-1 mediated tolerogenic dendritic cell differentiation.
Cheng DE; Hung JY; Huang MS; Hsu YL; Lu CY; Tsai EM; Hou MF; Kuo PL
Biochim Biophys Acta; 2014 Jun; 1840(6):1965-76. PubMed ID: 24468067
[TBL] [Abstract][Full Text] [Related]
27. Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis.
Du G; Jin L; Han X; Song Z; Zhang H; Liang W
Cancer Res; 2009 Apr; 69(7):3205-12. PubMed ID: 19318568
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
Sinha P; Clements VK; Ostrand-Rosenberg S
Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
[TBL] [Abstract][Full Text] [Related]
29. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
30. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
31. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
[TBL] [Abstract][Full Text] [Related]
32. Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation.
Chen L; Huang TG; Meseck M; Mandeli J; Fallon J; Woo SL
Mol Ther; 2007 Dec; 15(12):2194-202. PubMed ID: 17968355
[TBL] [Abstract][Full Text] [Related]
33. The deficiency of galectin-3 in stromal cells leads to enhanced tumor growth and bone marrow metastasis.
Pereira JX; Azeredo MC; Martins FS; Chammas R; Oliveira FL; Santos SN; Bernardes ES; El-Cheikh MC
BMC Cancer; 2016 Aug; 16():636. PubMed ID: 27526676
[TBL] [Abstract][Full Text] [Related]
34. Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.
Nambiar DK; Aguilera T; Cao H; Kwok S; Kong C; Bloomstein J; Wang Z; Rangan VS; Jiang D; von Eyben R; Liang R; Agarwal S; Colevas AD; Korman A; Allen CT; Uppaluri R; Koong AC; Giaccia A; Le QT
J Clin Invest; 2019 Dec; 129(12):5553-5567. PubMed ID: 31710313
[TBL] [Abstract][Full Text] [Related]
35. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.
Juszczynski P; Ouyang J; Monti S; Rodig SJ; Takeyama K; Abramson J; Chen W; Kutok JL; Rabinovich GA; Shipp MA
Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13134-9. PubMed ID: 17670934
[TBL] [Abstract][Full Text] [Related]
36. Splenectomy reduces lung metastases and tumoral and metastatic niche inflammation.
Stöth M; Freire Valls A; Chen M; Hidding S; Knipper K; Shen Y; Klose J; Ulrich A; Ruiz de Almodovar C; Schneider M; Schmidt T
Int J Cancer; 2019 Nov; 145(9):2509-2520. PubMed ID: 31034094
[TBL] [Abstract][Full Text] [Related]
37. Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.
Femel J; van Hooren L; Herre M; Cedervall J; Saupe F; Huijbers EJM; Verboogen DRJ; Reichel M; Thijssen VL; Griffioen AW; Hellman L; Dimberg A; Olsson AK
Cancer Immunol Immunother; 2022 Aug; 71(8):2029-2040. PubMed ID: 35018481
[TBL] [Abstract][Full Text] [Related]
38. Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function.
Wei S; Cao D; Liu Z; Li J; Wu H; Gong J; Liu Y; Wu Y
Cell Death Dis; 2018 Feb; 9(3):293. PubMed ID: 29463785
[TBL] [Abstract][Full Text] [Related]
39. Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma.
Erin N; Korcum AF; Tanrıöver G; Kale Ş; Demir N; Köksoy S
Brain Behav Immun; 2015 Aug; 48():174-85. PubMed ID: 25736062
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence.
Ito K; Ralph SJ
Clin Exp Metastasis; 2012 Aug; 29(6):561-72. PubMed ID: 22484915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
